How to realize the transformation of industrial model in pharmaceutical enterprises

With the general improvement of people's living standards in China, people are now very concerned about how to prolong life, how to solve sub-health and how to cure terminal diseases. The social demand for biomedical, medical devices, modern Chinese medicine and other medical-related industries is skyrocketing. However, the problem of sustainable development faced by the medical industry is also highlighted. Forward-looking Industrial Research Institute summarized the following points:

The first is environmental pollution. In the national pollution source survey bulletin issued by the Ministry of Environmental Protection, the pharmaceutical industry accounts for 1.7% of the national total industrial output value, while the sewage discharge accounts for 2%. Secondly, the problem of exhaustion of medicinal resources. More than 40% of wild medicinal resources are seriously exhausted, and there may be no file or even no medicine available in the next few years.

The transformation of industrial model is also a big problem. China Pharmaceutical Company mainly focuses on characteristic chemical raw materials and bulk chemical raw materials. This market not only has fierce competition and low profit, but also aggravates the problems of environmental protection and resource depletion. The R&D and patents of monopolistic and highly profitable "brand-new drugs" are mostly in the hands of multinational pharmaceutical companies. Therefore, upgrading the brand and encouraging innovation have become the direction of the mode transformation of pharmaceutical enterprises in China.

In a word, under the attack of international pharmaceutical brands, China pharmaceutical enterprises are facing the threat of sustainable development, and establishing brands and upgrading scientific research have become the only way for enterprises to realize transformation.